Alizyme plc

Industry

  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
    • Specialty Pharmaceuticals
See more in Biomedtracker

Latest on Alizyme plc

Scrip

Stock Watch: Funding Biotech In A Hostile Environment

 
• By Andy Smith

The NASDAQ Biotech Index is down by nearly 27% since the last peak, the IPO window is virtually shut, there is diminished appetite for secondary offerings, the situation has been made worse by the col

In Vivo

Deals Shaping The Medical Industry, February 2017

 
• By Steven Muntner, Amanda Micklus, Beth Allan, Maureen Riordan, and Deanna Kamienski

IN VITRO DIAGNOSTICS Mergers & Acquisitions PerkinElmer Inc. Tulip Diagnostics Pvt. Ltd. PerkinElmer Inc. is acquiring Indian firm Tulip Diagnostics Pvt. Ltd. (Jan.) Tulip focuses on assay sys

Scrip

Cetilistat approval puts Takeda first in Japan obesity market

 
• By Ian Haydock

The history of drug development for obesity in Japan is strewn with product casualties but Takeda has cleared a significant hurdle with the formal approval in this market of the lipase inhibitor Oblea

Scrip

Cetilistat could become first obesity drug in Japan as Takeda files for approval

 
• By Ian Haydock

Takeda has filed for the approval in Japan of the lipase inhibitor cetilistat, seeking regulatory clearance for the treatment of obesity with complications including type 2 diabetes and dyslipidaemia.